June Almenoff

2013

In 2013, June Almenoff earned a total compensation of $180.2K as Director at Ohr Pharmaceutical.

Compensation breakdown

Option Awards$180,157
Total$180,157

Almenoff received $180.2K in option awards, accounting for 100% of the total pay in 2013.

Rankings

In 2013, June Almenoff's compensation ranked 11,737th out of 12,286 executives tracked by ExecPay. In other words, Almenoff earned more than 4.5% of executives.

ClassificationRankingPercentile
All
11,737
out of 12,286
5th
Division
Manufacturing
4,397
out of 4,612
5th
Major group
Chemicals And Allied Products
1,391
out of 1,462
5th
Industry group
Drugs
1,105
out of 1,156
4th
Industry
Pharmaceutical Preparations
855
out of 890
4th
Source: SEC filing on March 7, 2014.

Almenoff's colleagues

We found five more compensation records of executives who worked with June Almenoff at Ohr Pharmaceutical in 2013.

2013

Thomas Riedhammer

Ohr Pharmaceutical

Director

2013

Irach Taraporewala

Ohr Pharmaceutical

Chief Executive Officer

2013

Sam Backenroth

Ohr Pharmaceutical

Chief Financial Officer

2013

Ira Greenstein

Ohr Pharmaceutical

Chairman

2013

Orin Hirschman

Ohr Pharmaceutical

Director

In-depth

You may also like